Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine

References

• Akhtar N, Ahad A, Khar RK, Jaggi M, Aqil M, Iqbal Z, Ahmad FJ, Talegaonkar S. The emerging role of P-glycoprotein inhibitors in drug delivery: A patent review. Expert Opin Ther Pat, 2011;21:561–76.
   PubMed Web of Science ®Google Scholar
• Artursson P, Palm K, Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev, 2012;64(Supplement):280–9.
   Web of Science ®Google Scholar
• Ashiru-Oredope DAI, Patel N, Forbes B, Patel R, Basit AW. The effect of polyoxyethylene polymers on the transport of ranitidine in Caco-2 cell monolayers. Int J Pharm, 2011;409:164–8.
   PubMed Web of Science ®Google Scholar
• Aulton ME. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. Edinburgh; New York: Churchill Livingstone; 2007.
   Google Scholar
• Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release, 2002;79:123–35.
   PubMed Web of Science ®Google Scholar
• Bala I, Hariharan S, Kumar M. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst, 2004;21:387–422.
   PubMed Web of Science ®Google Scholar
• Baseer A, Hassan F, Hassan SF, Jabeen SJ, Israr F, Murtaza G, Haque N.. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques. Pak J Pharm Sci, 2013;26:439–43.
   PubMed Web of Science ®Google Scholar
• Bhardwaj V, Hariharan S, Bala I, Lamprecht A, Kumar N, Panchagnula R, Kumar M. Pharmaceutical aspects of polymeric nanoparticles for oral drug delivery. J Biomed Nanotechnol, 2005;1:235–58.
   Web of Science ®Google Scholar
• Choi KM, Choi MC, Han DH, Park TS, Ha CS. Plasticization of poly(lactic acid) (PLA) through chemical grafting of poly(ethylene glycol) (PEG) via in situ reactive blending. Eur Polym J, 2013;49:2356–64.
   Web of Science ®Google Scholar
• Collnot EM, Baldes C, Wempe MF, Kappl R, Hüttermann J, Hyatt JA, Edgar KJ, Schaefer UF, Lehr CM. Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: Influence on ATPase activity and membrane fluidity. Mol Pharm, 2007;4:465–74.
   PubMed Web of Science ®Google Scholar
• Dahan A, Amidon GL. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: The role of efflux transport in the oral absorption of BCS class III drugs. Mol Pharm, 2008;6:19–28.
   Web of Science ®Google Scholar
• Elmowafy E, Awad G, Mansour S, El-Shamy A. Release mechanisms behind polysaccharides-based famotidine controlled release matrix tablets. AAPS PharmSciTech, 2008;9:1230–9.
   PubMed Web of Science ®Google Scholar
• Essa S, Rabanel JM, Hildgen P. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(d, l-lactide) (PLA) based nanoparticles. Eur J Pharm Biopharm, 2010;75:96–106.
   PubMed Web of Science ®Google Scholar
• Estudante M, Morais JG, Soveral G. a, Benet LZ. Intestinal drug transporters: An overview. Adv Drug Deliv Rev, 2013;65:1340–56.
   PubMed Web of Science ®Google Scholar
• Ferenczy GG, Parkanyi L, Angyan JG, Kalman A, Hegedus B. Crystal and electronic structure of two polymorphic modifications of famotidine. An experimental and theoretical study. J Mol Struct Theochem, 2000;503:73–9.
   Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur J Pharm Biopharm, 2008;69:1–9.
   PubMed Web of Science ®Google Scholar
• Gorner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J Control Release, 1999;57:259–68.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. J Control Release, 1999;57:171–85.
   PubMed Web of Science ®Google Scholar
• Gref R, Miralles G, Dellacherie É. Polyoxyethylene-coated nanospheres: Effect of coating on zeta potential and phagocytosis. Polym Int, 1999;48:251–6.
   Web of Science ®Google Scholar
• Hassouna F, Raquez JM, Addiego F, Dubois P, Toniazzo V, Ruch D. New approach on the development of plasticized polylactide (PLA): Grafting of poly(ethylene glycol) (PEG) via reactive extrusion. Eur Polym J, 2011;47:2134–44.
   Web of Science ®Google Scholar
• Hawley A, Illum L, Davis S. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res, 1997;14:657–61.
   PubMed Web of Science ®Google Scholar
• Hugger ED, Audus KL, Borchardt RT. Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. J Pharm Sci, 2002a;91:1980–90.
   PubMed Web of Science ®Google Scholar
• Hugger ED, Novak BL, Burton PS, Audus KL, Borchardt RT. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J Pharm Sci, 2002b;91:1991–2002.
   PubMed Web of Science ®Google Scholar
• Hugger ED, Cole CJ, Raub TJ, Burton PS, Borchardt RT. Automated analysis of polyethylene glycol-induced inhibition of P-glycoprotein activity in vitro. J Pharm Sci, 2003;92:21–6.
   PubMed Web of Science ®Google Scholar
• Hunter A, Elsom CJ, Wibroe PP, Moghimi SM. Polymeric particulate technologies for oral drug delivery and targeting: A pathophysiological perspective. Nanomed Nanotechnol Biol Med, 2012;8(Supplement 1):S5–20.
   PubMed Web of Science ®Google Scholar
• Iqbal J, Hombach J, Matuszczak B, Bernkop-Schnurch A. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor. J Control Release, 2010;147:62–9.
   PubMed Web of Science ®Google Scholar
• Jiang T, Han N, Zhao B, Xie Y, Wang S. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm, 2012;38:1230–9.
   PubMed Web of Science ®Google Scholar
• Kiho Lee CN, Brouwer KLR, Thanker DR. Secretory transport of Rantidine and Famotidine across CaCo-2 cell monolayers. J Pharmacol Exp Ther, 2002;303:574–80.
   PubMed Web of Science ®Google Scholar
• Kin-Kai DH, Giesing GH, Hurst Aventis Pharmaceuticals, Inc. Method of enhancing bioavailability of fexofenadine and its derivatives. US6451815; 2002.
   Google Scholar
• Lamprecht A, Ubrich N, Hombreiro Perez M, Lehr CM, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm, 2000;196:177–82.
   PubMed Web of Science ®Google Scholar
• Lenhardt T, Vergnault G, Grenier P, Scherer D, Langguth P. Evaluation of nanosuspensions for absorption enhancement of poorly soluble drugs: in vitro transport studies across intestinal epithelial monolayers. AAPS J, 2008;10:435–8.
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm, 2008;5:496–504.
   PubMed Web of Science ®Google Scholar
• Lin SY, Cheng WT, Wang SL. Thermodynamic and kinetic characterization of polymorphic transformation of famotidine during grinding. Int J Pharm, 2006;318:86–91.
   PubMed Web of Science ®Google Scholar
• Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, Laaksonen T, Peltonen L. Nanosuspensions of poorly soluble drugs: Preparation and development by wet milling. Int J Pharm, 2011;411:215–22.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: A formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 2003;18:113–20.
   PubMed Web of Science ®Google Scholar
• Mert O, Lai SK, Ensign L, Yang M, Wang YY, Wood J, Hanes J. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. J Control Release, 2012;157:455–60.
   PubMed Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release, 2007;119:77–85.
   PubMed Web of Science ®Google Scholar
• Monjed S, Gilles P, Elias F. Particle uptake by Peyer’s patches: A pathway for drug and vaccine delivery. Expert Opin Drug Deliv, 2004;1:141–63.
   PubMedGoogle Scholar
• Morakul B, Suksiriworapong J, Leanpolchareanchai J, Junyaprasert VB. Precipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: Influencing factors on physicochemical properties and stability. Int J Pharm, 2013;457:187–96.
   PubMed Web of Science ®Google Scholar
• Nadeau V, Leclair G, Sant S, Rabanel JM, Quesnel R, Hildgen P. Synthesis of new versatile functionalized polyesters for biomedical applications. Polymer, 2005;46:11263–72.
   Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Panoyan A, Quesnel R, Hildgen P. Injectable nanospheres from a novel multiblock copolymer: Cytocompatibility, degradation and in vitro release studies. J Microencapsul, 2003;20:745–58.
   PubMed Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: A promising drug delivery strategy. J Pharm Pharmacol, 2004;56:827–40.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Nandhakumar S, Dhanaraju MD. Formulation and characterization of glutaraldehyde cross-linked chitosan biodegradable microspheres loaded with famotidine. Trop J Pharm Res, 2011;10:309–16.
   Web of Science ®Google Scholar
• Rabanel J-M, Aoun V, Hildgen P. Impact of polymer physico-chemical properties on PEG-grafted-PLA nanoparticles structure. CRS 37th annual meeting; 2012a.
   Google Scholar
• Rabanel J-M, Aoun V, Elkin I, Mokhtar M, Hildgen P. Drug-loaded nanocarriers: Passive targeting and crossing of biological barriers. Curr Med Chem, 2012b;19:3070–102.
   PubMed Web of Science ®Google Scholar
• Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: In vitro characterisation and in vivo evaluation. J Control Release, 2001;70:353–63.
   PubMed Web of Science ®Google Scholar
• Rieux A, Fievez V, Garinot M, Schneider YJ, Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J Control Release, 2006;116:1–27.
   PubMed Web of Science ®Google Scholar
• Rozehnal V, Nakai D, Hoepner U, Fischer T, Kamiyama E, Takahashi M, Yasuda S, Mueller J. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs. Eur J Pharm Sci, 2012;46:367–73.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. London; Chicago : Washington, DC: Pharmaceutical Press; American Pharmacists Association; 2007.
   Google Scholar
• Sahoo NG, Kakran M, Shaal LA, Li L, Muller RH, Pal M, Tan LP. Preparation and characterization of quercetin nanocrystals. J Pharm Sci, 2011;100:2379–90.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 2002;82:105–14.
   PubMed Web of Science ®Google Scholar
• Sant S, Poulin S, Hildgen P. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. J Biomed Mater Res Part A, 2008;87:885–95.
   PubMed Web of Science ®Google Scholar
• Sepassi S, Goodwin DJ, Drake AF, Holland S, Leonard G, Martini L, Lawrence MJ. Effect of polymer molecular weight on the production of drug nanoparticles. J Pharm Sci, 2007;96:2655–66.
   PubMed Web of Science ®Google Scholar
• Shah VJP, Bagchi T, Misra A. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption. Biotechnol Prog, 2006;22:186–98.
   PubMed Web of Science ®Google Scholar
• Shen Q, Lin Y, Handa T, Doi M, Sugie M, Wakayama K, Okada N, Fujita T, et al. Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. Int J Pharm, 2006;313:49–56.
   PubMed Web of Science ®Google Scholar
• Shilpa S, Ve´ronique N, Hildgen P. Effect of porosity on the release kinetics of propafenone-loaded PEG-g-PLA nanoparticles. J Control Release, 2005;107:203–14.
   PubMed Web of Science ®Google Scholar
• Shoaib M, Al Sabah Siddiqi S, Yousuf R, Zaheer K, Hanif M, Rehana S, Jabeen S. Development and evaluation of hydrophilic colloid matrix of Famotidine tablets. AAPS PharmSciTech, 2010;11:708–18.
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 2001;70:1–20.
   PubMed Web of Science ®Google Scholar
• Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res, 1998;15:270–5.
   PubMed Web of Science ®Google Scholar
• Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: Effect of particle size and PEG coating density. J Control Release, 2004;98:231–44.
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Lizarraga E, Irache JM. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): Preparation and evaluation of their bioadhesive properties. Eur J Pharm Sci, 2005;24:411–19.
   PubMed Web of Science ®Google Scholar
• Yu L. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev, 2001;48:27–42.
   PubMed Web of Science ®Google Scholar